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Abstract: DR2B and DR2C extracts, obtained by ethanolic maceration of peel from commercially
and physiologically ripe aubergine berries, were studied for the antioxidative cytoprotective
properties and anti-HSV-1 activity, in line with the evidence that several antioxidants can impair
viral replication by maintaining reducing conditions in host cells. The antioxidative cytoprotective
effects against tBOOH-induced damage were assessed in Caco2 cells, while antiviral activity was
studied in Vero cells; polyphenolic fingerprints were characterized by integrated phytochemical
methods. Results highlighted different compositions of the extracts, with chlorogenic acid and
delphinidin-3-rutinoside as the major constituents; other peculiar phytochemicals were also identified.
Both samples reduced reactive oxygen species (ROS) production and exhibited scavenging and
chelating properties. DR2C partly counteracted the tBOOH-induced cytotoxicity, with a remarkable
lowering of lactate metabolism under both normoxia and hypoxia; interestingly, it increased
intracellular GSH levels. Furthermore, DR2C inhibited the HSV-1 replication when added for
24 h after viral adsorption, as also confirmed by the reduction of many viral proteins’ expression.
Since DR2C was able to reduce NOX4 expression during HSV-1 infection, its antiviral activity may be
correlated to its antioxidant properties. Although further studies are needed to better characterize
DR2C activity, the results suggest this extract as a promising new anti-HSV-1 agent.
Keywords: eggplant peel; polyphenols; HSV-1; Warburg effect; antioxidant activity; antiviral agents;
vegetable waste
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1. Introduction
Medicinal plants have played a central role as source of new bioactive molecules in the years,
thus leading to the discovery of more than half of the current pharmaceuticals. Also, they can be used
as crude extracts or “standard enriched fractions” in pharmaceutical preparations, or as home-made
remedies [1]. The strong interest for natural products is due to several factors, including the need
for new, more effective pharmacological agents, the remarkable scaffold diversity and biological
activities of natural molecules, and the numerous traditional uses in ethnomedicines, which often
support researchers in the selection of a suitable plant for pharmacological study [2]. Particularly, large
numbers of plant-derived products, including pure compounds, fractions, and crude extracts, have
been approached as possible new antimicrobial strategies against herpes simplex virus type 1 (HSV-1)
infections [3–5]. HSV-1 is a human enveloped-DNA virus that persists along with the lifetime of the host
in sensory neurons, where it establishes latency [6]. Its reactivation induces recurrent infections that
cause a broad spectrum of clinical symptoms, varying from mild skin vesicular lesions to severe and
rare manifestations, such as encephalitis and keratitis, especially during immune deficit conditions [7].
The administration of the antiviral agent acycloguanosine (acyclovir) is the primary therapeutic
approach to inhibit HSV-1 infections, but not to avoid recurrence arising from the reactivation of the
latent virus [8,9]. Therefore, looking for new bioactive agents against HSV-1 infections, to be used as
alternative or complementary treatments, is emerging as an important requirement for human health.
Recently, polyphenols, isoprenoidal glycosides, phenolics, peptides, benzophenones,
and pyranocoumarins have been studied for their potential anti-HSV-1 properties [10–12].
Particularly, flavonoids and anthocyanins have been found to possess anti-HSV-1 effects, likely due to
antioxidant mechanisms [10,13]. In fact, it is known that viral infections, including HSV-1, are often
associated with oxidative stress that is useful for the virus to replicate in cells [14–16], and antioxidant
molecules, like glutathione (GSH) or its n-butanoyl derivative (GSH-C4), by restoring the intracellular
redox conditions, are able to inhibit HSV-1 replication [17–19].
In line with this evidence, the present study was aimed at evaluating the potential antiherpetic
activity of Solanum melongena L., commonly known as eggplant, aubergine, or brinjal. Besides the
culinary interest, this species has been used for several medicinal purposes in folk medicine,
particularly by Asiatic people [20,21]. It is reported to be topically applied for treating several skin
diseases, including dermatitis, eczema, sores, infections, and human papilloma virus-caused warts and
condylomata [22,23]. Also, glycoalkaloids from eggplant have been reported to counteract free radical
damage, thus showing skin-protective power [24]. Several studies also described the health benefits
associated with phenolics extracted from eggplant, thus suggesting its possible role as a nutraceutical
source [25]. A remarkable diversity in polyphenols was found in this plant, with chlorogenic acid and
the anthocyanins delphinidin 3-rutinoside (D3R) and/or nasunin (NAS) as the main types represented,
especially in the peel [26,27]. These compounds have been reported to possess a wide spectrum of
nutraceutical properties, such as antioxidant, antiproliferative, and anti-inflammatory [28–32]; also,
chlorogenic acid has been found to possess multi-antiviral activities [32].
Taking into account this evidence, in the present study, we evaluated the potential antioxidative
cytoprotective effects and the anti-herpetic activity of the DR2B and DR2C extracts, obtained by
ethanolic maceration of the berry peel of S. melongena L. DR2 genotype, collected at both commercial
(B) and physiological (C) ripening stages, as reported by Mennella et al. [33].
Polyphenol fingerprints were characterized by integrated chromatographic (HPTLC and HPLC)
and spectrophotometric techniques, in order to evaluate the possible contribution of these compounds
to the biological activity of DR2B and DR2C extracts. The antioxidant cytoprotective effects against
the oxidative damage induced by tert-butylhydroperoxide (tBOOH) were studied in human colon
cancer Caco2 cells, which are sensitive to oxidant injury and represent a widely standardized model for
studying oxidative stress and metabolic fate of oxidant species [34,35]. In these cells, we also studied
if the treatments affected the levels of reactive oxygen species (ROS), content of reduced glutathione
(GSH), and cell metabolism as a result of the antioxidant activity. The radical scavenging activity and
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the iron chelating/reducing properties were assayed too. At last, taking into account the key role of
intracellular redox state in regulating viral replication, DR2B and DR2C extracts were also assessed
for their potential anti-HSV1 activity in monkey kidney epithelial (Vero) cells, known to be highly
permissive to the virus [36].
2. Results and Discussion
2.1. Phytochemical Analysis
Colorimetric determinations highlighted the presence of total polyphenols and flavonoids in all
the samples of DR2 aubergine. Particularly, the amounts of polyphenols and flavonoids were found
increased in DR2C with respect to DR2B extract (amount about doubled and tripled for polyphenols
and flavonoids respectively) (Table 1).
Table 1. Amounts of total polyphenols and flavonoids in DR2B and DR2C extracts (n = 6).
Compound
DR2B DR2C
µg/mg Sample (Mean± SE)
Total polyphenols (CAE) 39.0 ± 0.08 67.0 ± 0.04 **
Flavonoids (QE) 3.3 ± 0.01a 9.8 ± 0.01b **
CAE, chlorogenic acid; QE, quercetin equivalents. a 1.8 ± 0.01 µg CAE/mg extract. b 5.3 ± 0.01 µg CAE/mg extract.
** p < 0.01 denotes significant increased levels respect to DR2B by Student’s t-test.
Eggplant is known to contain high levels of phenolic compounds, mainly phenolic acids
(chlorogenic acid, caffeic acid, p-coumaric acid) in pulp and anthocyanins, such as NAS and delphinidin
conjugates in the peel [37,38]. Total phenolic content has been found varied in different extracts, with
acidified ethanol being the most frequently used extraction solvent. Fresh eggplant peels were found
to contain high levels of total phenols, with major differences due to the extraction method [39,40].
Lower amounts were reported in the extracts of whole fresh fruits [41] and in those from dried
peels [42]. Several factors have been shown to affect the phenolic amount of eggplant, among which,
the harvesting period [43,44].
Under our experimental conditions, the ratio between the total amounts of polyphenols and
flavonoids, calculated as chlorogenic acid equivalents, was about 21.7 and 12.6 for DR2B and DR2C,
respectively: this suggests that physiological ripeness markedly increases the flavonoid levels in
DR2 eggplant peel. Our results agree with literature that reported flavonoids generally representing
about 10–15% of total phenolics in eggplant [45].
On the basis of the drug extract ratio (DER) values obtained for each sample (i.e., DR2B, 23:1; DR2C,
25:1), the total flavonoid amount was estimated to be 140 mg/kg (0.014% w/w) and 392 mg/kg (0.039 %
w/w) in the raw material from DR2B and DR2C aubergine berries, respectively. According to Peterson
and Dwyer [46], who classified the flavonoid concentration in foods as low (0.1–39.9 mg/kg), moderate
(40–99.9 mg/kg), and high (>100 mg/kg), the peels of DR2B and DR2C aubergine berries produced samples
with high flavonoid contents. Similar results were reported by Ji et al. [47], which found a total flavonoid
amount of 116.4 mg/kg of fresh eggplant peel, in spite of undetectable levels in the pulp. Lower amounts
of flavonoids and tannins were found in ethanolic extract from dried eggplant peels [40,42].
The HPTLC analysis of DR2B and DR2C extracts revealed the presence of several polyphenols,
mainly visualized as fluorescent spots at 366 nm after derivatization with NPR (Figure S1).
HPTLC analysis was also performed on the extract from the pulp and the edible part of DR2 aubergine
berries at both ripening stages. The pulp represented the mesocarp of the fruit, obtained after peel
separation, while the edible part was the pericarp after removing the calix. Also, control aubergine
berries from a 67/3 variety of S. melongena obtained from the same experimental fields, was included
in the analysis (Figure S1). The edible part exhibited a polyphenolic fingerprint similar to that of the
relative peel, with lower amounts as evidenced by the fluorescence intensity of the spots; conversely,
in pulp samples, several compounds disappeared, thus suggesting that peel represents the mainly
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phenolic-enriched part of aubergine berries. Comparing the control eggplant and DR2, a similar trend
was found at different ripening stages, with some differences in the upper part of chromatogram
(Figure S1). The HPTLC chromatograms highlighted the presence of rutin, chlorogenic acid, caffeic
acid, and epicatechin in both DR2B and DR2C samples (Figure S2). Conversely, apigenin was a peculiar
compound of DR2C extract (Figure S2, Table 2).
Among phytochemicals identified and determined by densitometric analysis, chlorogenic acid
and rutin were found to be ubiquitous, with a significantly increased content in DR2B extract respect
to DR2C (Figure S2; Table 2). The control 67/3C eggplant sample contained chlorogenic acid, rutin,
apigenin, while it was lacking epicatechin and caffeic acid (Figure S1). Regarding anthocyanins, D3R
was found to be the most abundant compound at both ripening stages, with low amounts of NAS and
delphinidin-3-O-β-D-glucoside: the ratio between D3R and NAS was about 18 and 19 for DR2B and
DR2C, respectively; this confirms that it represents the characteristic anthocyanin of DR2 eggplant
variety, in agreement with what reported by Mennella et al. [33].
Anthocyanins were found abundant in these extracts from aubergine, with a total amount of 0.53
± 0.012 mg cyanidin-3-glucoside equivalent and 76.44 ± 3.82 mg of D3R equivalent per 100 g of fresh
fruit [39,41]. The acidified ethanolic extract from eggplant peel was found to contain 62.92 ± 0.15 mg
delphinidin-3-glucoside equivalent/100 g of extract, with a ratio between anthocyanins and flavonoids of
about 4 [42].
Although for our samples the total anthocyanin amount was not determined, taking into
account that DR2 eggplant mainly produces delphinidin-3-glucoside as a peculiar anthocyanin [33],
we estimated the ratio between anthocyanins and flavonoids was about 35 and 9 for DR2B and DR2C,
respectively. This suggests that ripening increases the flavonoid amount, although anthocyanins
were important constituents of eggplant peel. DR2B and DR2C extracts were also characterized
by the presence of chlorogenic acid as a representative hydroxycinnamic acid, with a significant
lowered amount (about 2.4-fold lower than DR2B) for ripening stage C. The seasonal variations of
phenolic compounds have been also reported for other Solanaceae species: a decreased concentration
of chlorogenic acid was found in long eggplants (about 70% lower levels), as well as in other species
such as tomato (about a 43% reduced levels) with rising temperatures due to the summer season [43,48].
The levels of phenolic acids have also been found increased in relation to the organic growth, thus
suggesting that they can be produced as a plant response to environmental stressors [49].
For eggplant varieties containing D3R, Mennella et al. [33] reported a 1.5-fold reduction of
chlorogenic acid and total polyphenols ratio at the physiological ripening stage, with respect to the
commercial one. For our samples, we found that the chlorogenic acid and total polyphenols ratio was
about 1.5 and 0.4 for DR2B and DR2C extracts, respectively, with a reduction of 3.7-fold: this can be
explained on the basis of the lower amounts of chlorogenic acid and the high anthocyanin levels in
eggplant peel with respect to the pulp.
Table 2. Levels of polyphenols and anthocyanins measured by the HPTLC densitometric analysis in
DR2B and DR2C extracts (n = 3).
Compound
DR2B DR2C
µg/mg Sample (Mean± SD)
Apigenin nd 15.7 ± 0.8 **
Caffeic acid 1.7 ± 0.1 2.2 ± 0.1 *
Chlorogenic acid 60.7 ± 3.2 24.5 ± 1.8 **
Delphinidin 3-O-β-D-glucoside 10.1 ± 0.7 nd **
Delphinidin-3-rutinoside 115.0 ± 0.2 90.3 ± 2.6 **
Epicatechin 8.7 ± 0.4 5.3 ± 0.3 **
Nasunin 6.3 ± 0.4 4.7 ± 0.6 *
Rutin 1.9 ± 0.1 1.1 ± 0.1 *
nd, not detected. * p < 0.05 and ** p < 0.01 denote significant differences respect to DR2B by Student’s t-test.
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The phenolic fingerprint of the extracts was also detected by HPLC-PDA analysis [50], showing a
different pattern for DR2B and DR2C samples (expressed as µg/mg of dry extract) (Table 3; Figure S3).
Collectively, DR2B extract was characterized by a predominant presence of chlorogenic acid and a low
amount of gallic acid, while DR2C displayed appreciable amounts of chlorogenic acid, t-ferulic acid,
and t-cinnamic acid, along with small quantities of gallic acid, vanillic acid, naringin, syringic acid,
3-OH-4-MeO benzaldehyde, and 2,3-diMeO benzoic acid (Table 3).
García-Salas et al. [43] previously found the whole long eggplant to contain the flavonols quercetin
3,4′-O-diglucoside and kaempferol-3-O-rutinoside, hydroxycinnamic acids, homovanillic acid hexose,
and delphinidin-3-O-rutinoside. Accordingly, Singh et al. [51] reported eggplant contains chlorogenic
acids, with traces of quercetin and myricetin glucosides. Hydroxycinnamic acid conjugates were
peculiar to the whole aubergine berry and pulp [44]; however, chlorogenic acid, ferulic acid, and caffeic
acid were also found in the eggplant peel [38,52]. A complex flavonol profile was described for the
eggplant skins [49], in spite of a low amount for the pulp [51]. Our results on the peel extracts from
DR2 aubergine berries partly agree with literature evidence, mainly regarding the hydroxycinnamic
acid composition, while the flavones apigenin and naringenin were firstly identified. Naringenin was
also found to be transported and incorporated in the outer cuticle matrix [53], while apigenin was
reported abundant in eggplant leaves [54].
Table 3. Phenolic composition of DR2B and DR2C extracts by HPLC- PDA analysis.
Compound
DR2B DR2C
µg/mg of Sample (Mean± SD)
3-OH-4-MeO Benzaldehyde nd BLD
Benzoic acid nd nd
2,3-diMeO Benzoic acid nd BLD
3-OH Benzoic acid nd nd
p-OH Benzoic acid nd nd
Catechin nd nd
Chlorogenic acid 62.7 ± 6.2 28.5 ± 3.1 **
t-Cinnamic acid nd 2.3 ± 0.2 **
o-Coumaric acid nd nd
p-Coumaric acid nd nd
t-Ferulic acid nd 7.3 ± 0.6 **
Gallic acid 0.6 ± 0.06 0.5 ± 0.05
Harpagoside nd nd
Naringenin nd nd
Naringin nd 0.4 ± 0.04 **
Quercetin nd nd
Rutin nd nd
Sinapinic acid nd nd
Syringic acid nd BLD
Vanillic acid nd 0.9 ± 0.09 **
BLD, below limit of detection; nd, not detected. ** p < 0.01 denotes significant differences respect to DR2B by
Student’s t-test.
2.2. DR2C Extract Exerts Cytoprotective Effect against Oxidative Cell Damage
Considering the characteristic polyphenolic composition, DR2B and DR2C were assayed for
their ability to interfere with the oxidative injury induced by the known oxidative agent tert-butyl
hydroperoxide (tBOOH) in Caco2 cells, which represent a sensitive biological model to oxidant
injury and have been widely used to study the effect of reactive oxygen metabolites and antioxidant
agents [34]. The effect was evaluated under both normoxia and CoCl2-induced hypoxia, during
which respiratory distress and oxidative stress occur as a result of the altered oxygen homeostasis [55].
In mammalian systems, CoCl2 is known to mimic hypoxia through stabilization of HIF-1α [56].
Preliminary experiments showed that DR2B-induced cytotoxicity signs starting from the concentration
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of 300 µg/mL, with a maximum inhibition of cell viability of about 30% with respect to control
(Figure S4). Conversely, DR2C extract was nontoxic under both normoxic and hypoxic conditions,
and slightly reduced the lactate levels extruded by treated cells (Figure S4).
In the antioxidative cytoprotective assay, the pro-oxidant agent tBOOH reduced cell viability
by about 40% with respect to the control under both normoxia and hypoxia (Figure 1A,C), with an
increased lactate metabolism with respect to control of about 40% and 30%, respectively (Figure 1B,D).
The DR2C extract displayed cytoprotective effects by inhibiting the tBOOH-induced cytotoxicity of
about 21% and 23% under normoxia and hypoxia (Figure 1A,C): under these experimental conditions,
lactate levels induced by tBOOH were found to be markedly reduced by DR2C (Figure 1B,D), reaching
a maximum inhibition of 67% and 58% under normoxia and hypoxia.
A slight but significant cytoprotection (lower than 10% increase of cell viability), with a 42%
reduction of tBOOH-induced lactate metabolism, was also found at the lowest concentration of DR2B
under normoxic conditions (Figure 1A,B). These results are remarkable, and highlight that the tested
extracts can counteract the oxidative damage, thus blocking the tBOOH-induced upregulation of
Warburg effect.
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Figure 1. Effect of DR2B and DR2C extracts (100–500 µg/mL) on the oxidative damage induced by
tert-butyl hydroperoxide (tBOOH; 5 µM) in Caco2 cells under normoxia and CoCl2-induced hypoxia.
The pro-oxidant agent tBOOH was added to cells after a 24 h pre-treatment with the extracts. (A,C)
Cell viability expressed as % of control. (B,D) Lactate levels normalized to the number of viable cells.
Data are mean ± SE from two independent biological replicates, each one performed in two technical
replicates (n = 2). * p < 0.05 and ** p < 0.01 vs. tBOOH by ANOVA followed by Dunnett’s multiple
comparison post-test.
Caco2 cells, along with several types of cancer cells, are characterized by peculiar energetic
requirements, due to their need to grow quickly with respect to normal cells. Therefore, they give a
modified metabolism with increased aerobic glycolysis and lactate production. This glycolytic phenotype,
known as the Warburg effect, leads to an increased nontoxic oxidative stress with a loss of antioxidant
capabilities and seems to be responsible for a highly resistant and malignant behavior of cancer cells [57].
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When Caco2 and other glycolytic cancer cells are subjected to an exogenous oxidative stressor, ROS
increase over tolerable levels; therefore, resistant cells markedly upregulate their glycolytic metabolism
to overcome oxidative injury [58]: as a consequence, high lactate levels are extruded by cells with an
increased steady-state ROS condition [57]. In this context, affecting the glycolytic phenotype of Caco2 cells
can represent a measure of the antioxidant power of the tested samples.
Literature evidence suggests a possible involvement of anthocyanins in the registered effects, since
both NAS and D3R displayed protective properties in osteoclasts against the tBOOH-induced oxidative
damage, likely by scavenging free radicals. This effect could be ascribed to the –OH moieties on the B ring,
to the number of OH– moieties in total, or to the type and extent of glycosylation and acylation [59,60].
Along with anthocyanins, the tested samples are important source of phenylpropanoids, mainly chlorogenic
acid (Table 3).
In this context, here, we also evaluated the antioxidant cytoprotective activity of chlorogenic acid,
in order to highlight its involvement in the activity of the extracts. Under our experimental conditions,
chlorogenic acid induced nontoxic effects up to the highest concentration revealed in the DR2C extract
(about 200 µg/mL), with a significant reduction of lactate levels under hypoxia (Figure 2A). When assessed
for cytoprotection, the substance induced only a slight inhibition of the tBOOH-induced cytotoxicity
(Figure 2B), in spite of a remarkable lowering of t-BOOH-induced lactate secretion (about 40% and 60%
reduction under normoxia and hypoxia, respectively) (Figure 2C). This suggests that this compound can
partly contribute to the activity of the extracts, although it does not represent the only bioactive constituent.
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significant increase of ROS level induced by tBOOH (about 3‐fold increase), both DR2B and DR2C 
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Figure 2. Effect of chlorogenic acid (50–200 µg/mL) on the oxidative damage induced by
tert-butyl hydroperoxide (tBOOH; 5 µM) in Caco2 cells under normoxia and CoCl2-induced hypoxia.
The pro-oxidant agent tBOOH was added to cells after a 24 h pre-treatment with the substance. (A) Cell
viability was expressed as % of control. (B) Cell viability in the presence of the oxidative agent tBOOH
expressed as % of control. (C) Lactate levels normalized to the nu ber of viable cells. Data are mean ±
SE from two independent biological replicates, each n perform d in two t hnical replicat (n = 2).
* p < 0.05 and ** p < 0.01 vs. tBOOH by ANOVA followed by Dunnett’s multiple comparison post-test.
In order to better characterize the antioxidant cytoprotective effects of the tested samples, we also
measured if the treatments may affect the intracellular content of ROS and GSH. In spite of a significant
increase of ROS level induced by tBOOH (about 3-fold increase), both DR2B and DR2C extracts,
and chlorogenic acid, significantly lowered the tBOOH-induced ROS levels, with a reduction of about
32%, 35%, and 45% respectively (Figure 3A).
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GSH levels were found reduced by tBOOH by about 25% with respect to the control; DR2B
extract did not affect the tBOOH-induced GSH levels, while in the presence of DR2C and chlorogenic
acid, the GSH content was significantly restored with respect to tBOOH treatment (about 1.5- and
1.8-fold, respectively) (Figure 3B). These results suggest that DR2C extract and chlorogenic acid not
only counteract the oxidative damage of tBOOH, but also restore the antioxidative cell defenses, which
are known to be downregulated in cancer cells, and modulate lactate production: altogether, these
mechanisms can contribute to their antioxidative cytoprotective effects. However, the involvement of
other specific factors or signaling pathways cannot be excluded.
The present results agree with a previous study, in which eggplant stalks were found to possess
cytoprotective, antioxidative, and anti-inflammatory properties, thus suggesting possible further
interest for eggplant product waste as a source of nutraceuticals and new pharmaceutical agents [61].
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also evaluated for the DR2B and DR2C extracts by spectrophotometric assays. The scavenging activity 
was evaluated against both synthetic DPPH• and ABTS•+ radicals and against the hydroxyl radical. 
Under our experimental conditions, both DR2B and DR2C extracts (5–2500 μg/mL) inhibited, in 
a significant and concentration dependent manner, the DPPH• and ABTS•+ radicals, with a higher 
potency of DR2C (Figure 4A,B): the IC50 value of DR2C was about 2.7‐ and 3.6‐fold lower than that of 
DR2B  (Table 4). The positive control Trolox was about 54‐ and 39‐fold more effective  than DR2C 
against DPPH and ABTS, respectively. 
Table 4. IC50 values of DR2B and DR2C extracts and the positive controls in the antioxidant activity assays. 
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DPPH scavenging activity  731.1 (681.7–784.2)  269.1 (207.60–348.9)  4.9 a (4.4–5.6) 
ABTS scavenging activity  277.6 (216.0–356.8)  77.6 (62.0–97.2)  1.9 a (1.8–2.0) 
Hydroxyl radical inhibition  595.1 (480.7–736.9)  727.3 (566.0–934.7)  87.6 a (83.2–91.2) 
Fe2+‐chelating activity  228.4 (185.9–280.6)  249.3 (210.6–295.0)  431.6 b (318.2–543.5) 
Fe3+‐chelating activity  391.1 (204.6–747.8)  143.2 (90.9–225.6)  45.2 c (13.1–75.5) 
Fe3+‐reducing activity  ‐  ‐  0.4 a (0.3–0.5) 
‐ not evaluable since the maximum inhibition at the highest tested concentration was lower than 80%. 
CL, confidence limits. a Trolox; b rutin; c quercetin. 
Figure 3. Effect of DR2B (100 µg/mL), DR2C (100 µg/mL), and chlorogenic acid (50 µg/mL) on
the ROS and GSH levels induced by tert-butyl hydroperoxide (tBOOH; 5 µM) in Caco2 cells under
normoxia. (A) Reactive oxygen sp cies (ROS) evel expressed as oxidation index with respect to the
basal levels. (B) GSH levels measured in cell lysates were normalized to viable cells and expressed
as a percentage (level from control cells was considered 100%). Data are mean ± SE from at least
two independent biological replicates (n = 2). § p < 0.01 vs. control; *** p < 0.001 and ** p < 0.01 vs.
tBOOH by ANOVA followed b Dunnett’s multiple comparison post-test.
2.3. Antioxidant Activity Assays
Different a tioxidant mechanisms, i cluding radical scav nging and chelating activity, were also
evaluated for the DR2B and DR2C extracts by spectrophotometric assays. The scavengin activity was
evaluated against both synthetic DPPH• and ABTS•+ radicals and against the hydroxyl radical.
Under our experimental conditions, both DR2B and DR2C extracts (5–2500 µg/mL) inhibited,
in a significant and concentration dependent manner, the DPPH• and ABTS•+ radicals, with a higher
potency of DR2C (Figure 4A,B): the IC50 value of DR2C was about 2.7- and 3.6-fold lower than that
of DR2B (Table 4). The positive control Trolox was about 54- and 39-fold more effective than DR2C
against DPPH and ABTS, respectively.
Table 4. IC50 values of DR2B and DR2C extracts and the positive controls in the antioxidant activity assays.
DR2B DR2C Positive Control
IC50 (CL) µg/mL
DPPH scavenging activity 731.1 (681.7–784.2) 269.1 (207.60–348.9) 4.9 a (4.4–5.6)
ABTS scavenging activity 277.6 (216.0–356.8) 77.6 (62.0–97.2) 1.9 a (1.8–2.0)
Hydroxyl radical inhibition 595.1 (480.7–736.9) 727.3 (566.0–934.7) 87.6 a (83.2–91.2)
Fe2+-chelating activity 228.4 (185.9–280.6) 249.3 (210.6–295.0) 431.6 b (318.2–543.5)
Fe3+-chelating activity 391.1 (204.6–747.8) 143.2 (90.9–225.6) 45.2 c (13.1–75.5)
Fe3+-reducing activity - - 0.4 a (0.3–0.5)
- not evaluable since the maximum inhibition at the highest tested concentration was lower than 80%. CL, confidence
limits. a Trolox; b rutin; c quercetin.
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Figure 4. Scavenging activity of DR2B and DR2C extracts against DPPH (A), ABTS (B), and hydroxyl
(C) radicals. Data are mean ± SE from two independent experiments, with each one performed with
3 technical replicates (n = 6).
According to the Pearson analysis, the scavenger activities against DPPH and ABTS radicals were
significantly correlated for both DR2B and DR2C extracts (Tables 5 and 6), although they exhibited
higher potency against ABTS with respect to DPPH radical (2.6- and 3.4-fold respectively). DPPH is
a pre-existing radical which can be neutralized by electron or hydrogen transfer, thus forming a
stable diamagnetic molecule; conversely, ABTS cation, generated j st before the exp riments through
different activators, requires an electron-transfer process t be scavenged, nd is more reactive than
DPPH [62]. These important chemical features can lead to different affinities and kinetics reactions,
and in the scavenging potencies. Our results suggest a major involvement of electronic transfer as
scavenging mechanism. Taking into account ABTS requires an aqueous reacti m dia; in spite of
the methanolic or et anolic vironment of DPPH, we hypothesize that radical sca enging effects of
DR2B and DR2C extracts are mainly due to polar bioactive constituents.
The extracts were also assayed for their ability to neutralize hydroxyl radical, thus resulting in
both being able to scavenge this ROS metabolite, in a significant and concentrati n- ependent manner,
with DR2B being slig tly more potent than DR2C (Figure 4C; T ble 4). The positive control Trolox
resulted at least 10-fold more potency than the tested extracts (Table 4).
As estimated by the Pearson analysis, for all the samples, DPPH, ABTS, and hydroxyl radical
scavenger activities were significantly correlated, with a correlation coeffi ient from 0.91 to 0.99 (Tables 5
and 6). The correlation of DPPH and hydroxyl radical sc venger activity could be due to their common
high reactivity, and suggests the presence in the extracts of some constituents able to counteract both
species, among which includes phenolic compounds with multiple hydroxyl groups (i.e., caffeic acid
and gallic acid) [63]. However, due to the low levels of t ese ompounds in the extracts (Table 3), high
concentrations of the samples are required for exerting the scavenger activity. Taking into account the
phytochemical composition (Tables 2 and 3), the contribution of phenolic acids, flavonoids (or flavonoid
glycosides), and anthocyanins to the radical scavenger activity of the extracts is expected. In fact, numerous
naturally occurring flavonoids have been highlighte to possess hy roxyl radical scavenging properties,
and to interfere wit oth r ROS species, thus sugg sting their import t protective role for health [64].
Hydroxyl radical is a strongly reactive radical which can cause serious damage to biomolecules, such
as lipids, proteins, and nucleic acids. Due to its extremely high reaction rate, reducing its generation,
for instance, by blocking the Fenton reaction, appears to be a suitable antioxidant trat gy for preventing
its damage. ROS species production can be f cilitated by elemental species, such as iron: ferrous ions
induce metal-catalyzed oxidation and participate in hydroxyl radical-generating Fenton type reactions;
ferric ions also produce radicals from peroxides, although the rate is 10-fold less than that of ferrous
ion [65]. Here, we assessed the ability of DR2B and DR2C extracts to indirectly affect ROS generation
by reducing and/or chelating iron through the formation of ferrous/ferrozine complex [66]. Under our
experimental conditions, both samples exerted a weak ferric reducing activity, thus hindering evaluation of
IC50 (Table 4). Conversely, they were effective as chelators of both ferrous and ferric ions, with almost 3-fold
high potency of DR2C as chelators of ferric ions (Figure 5A), in spite of a similar potency against ferrous
ions (Figure 5B). As estimated by the Pearson analysis, the chelating and radical scavenging activities of
the extracts appeared to be significantly correlated among them (Tables 5 and 6).
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Figure 5. Chelating activity of DR2B and DR2C extracts against ferric (A) and ferrous (B) ions. Data are
mean ± SE from two independent experiments, each one performed in 3 technical replicates (n = 6).
The antioxidant capacity of eggplant is ranked in the top ten of 120 different vegetables,
although some differences can occur due to variety, fruit shape, and size and methodology [25].
Jung et a . [40] and Nish et al. [41] reported the DPPH radical scavenging and metal chelating
properties of eggplant peel, while Kaneyuki et al. [67] found strong scavenging effects against
hydroxyl radical generation. Different extracts from fresh aubergine berry peel produced radical
scavenging effects against DPPH and hydrogen peroxide, and metal chelation, which were
mainly related to phenolics [42]. Singh et al. [49] also described the ability of skin eggplant to
inhibit the cupric ion-mediated lipoperoxidation. Likewise, aubergine berries exhibited radical
scavenging and chelating activities [26,68]. Mennella et al. [33] also suggest the involvement of
several bioactive constituents to the scavenging activity of NAS-type (containing nasunin as major
anthocyanin) and D3R-type (containing delphinidi -3-ruti oside as major anthocyanin) eggplant
varieties. Higher antioxid t capacities were also reported for semi-purified peel extracts from
D3R-type and NAS-type aubergine berries respect to the purified D3R and NAS anthocyanins [69],
thus confirming that other phytochemicals besides anthocyanins are involved in the antioxidant
activity of the phytocomplex. Accordingly, our results suggest that several components of the DR2B
and DR2C phytocomplex can contribute to the described antioxidant activity, acting by direct (by
neutralizing DPPH, ABTS, and hydroxyl radical) and/or indirect (as chelators of ferrous and ferric
ions) mechanisms. Among phytochemicals, the antioxidant properties of chlorogenic acid and
the esters formed between caffeic and quinic acids are widely reported [70]. On the other hand,
the radical scavenging and chelating effects of different polyphenols and anthocyanins have been
published [28,29,37,71]. Particularly, delphinidin glucosides have shown to poss ss th strongest
scavenging activity against superoxide anion and peroxynitrite, and NAS has been demonstrated to be
a potent superoxide anion radical scavenger [69]. However, along with polyphenols and anthocyanins,
a possible role of other unidentified phytochemicals in the biological activity of DR2 eggplant peel
cannot be excluded.
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Table 5. Pearson correlation coefficient among antioxidant activity assays for DR2B extract.
Pearson r (CL; R Square)
DPPH Scavenger Activity ABTS Scavenger Activity Hydroxyl Radical Scavenger Activity Fe2+-Chelating Activity Fe3+-Chelating Activity
DPPH scavenger activity 1 - - - -
ABTS scavenger activity 0.96 ** (0.67–0.99; 0.92) 1 - - -
Hydroxyl radical
scavenger activity 0.99 *** (0.98–0.99; 0.99) 0.95 * (0.41–0.99; 0.90) 1 - -
Fe2+-chelating activity 0.89 ** (0.42–0.98; 0.80) 0.99 *** (0.95–0.99; 0.99) 0.90 * (0.31–0.99; 0.8) 1 -
Fe3+-chelating activity 0.96 *** (0.75–0.99; 0.92) 0.98 *** (0.80–0.99; 0.95) 0.97 ** (0.74–0.99; 0.94) 0.96 ** (0.73–0.99; 0.92) 1
* p < 0.05, ** p < 0.01, and *** p < 0.001, statistically significant correlation (two-tailed t-test). CL, confidence limits.
Table 6. Pearson correlation coefficient among antioxidant activity assays for DR2C extract
Pearson r (CL; R Square)
DPPH Scavenger Activity ABTS Scavenger Activity Hydroxyl Radical Scavenger Activity Fe2+-Chelating Activity Fe3+-Chelating Activity
DPPH scavenger activity 1 - - - -
ABTS scavenger activity 0.88 * (0.26–0.99; 0.78) 1 - - -
Hydroxyl radical
scavenger activity 0.91 * (0.37–0.99; 0.83) 0.99 ** (0.86–0.99; 0.98) 1 - -
Fe2+-chelating activity 0.99 *** (0.98–0.99; 0.99) 0.91 * (0.35–0.99; 0.82) 0.92 * (0.4–0.99; 0.84) 1 -
Fe3+-chelating activity 0.98 *** (0.88–0.99; 0.97) 0.96 ** (0.70–0.99; 0.93) 0.89 * (0.27–0.99; 0.79) 0.99 *** (0.92–0.99; 0.98) 1
* p < 0.05, ** p < 0.01, and *** p < 0.001, statistically significant correlation (two-tailed t-test). CL, confidence limits.
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2.4. DR2C Extract Affects HSV-1 Replication
Several studies have reported that viral infections are often associated with an imbalance
in the intracellular redox state of host cell, that shifts towards pro-oxidant conditions [72,73].
Redox alterations are useful for the virus, since many pathways involved in the regulation of viral
replication and host responses are highly responsive to even transient changes in the redox state of
the cytoplasmic environment [74,75]. For this reason, several antioxidant molecules, both natural and
synthesized, have been reported to exert antiviral activity [5,13,17,76–78]. Therefore, based on the
above results relating to antioxidant properties of DR2B and DR2C extracts, their potential antiviral
activity against HSV-1 was studied. To this aim, a plaque reduction assay was performed: confluent
monolayers of VERO cells were infected with HSV-1 at multiplicity of infection (m.o.i.) of 1 for 24 h in
the presence of increasing concentrations of both the extracts, ranging from 1 µg/mL to 500 µg/mL.
DMSO-treated HSV-1-infected cells were used as control. Plaque formation was scored two days
later. The dose–response curves, shown in Figure 6A, demonstrate that DR2C inhibited HSV-1 plaque
formation in a dose-dependent manner with respect to DMSO-treated cells. In particular, the higher
inhibition of viral replication was reached with 500 µg/mL of the extract (about 2.5 log inhibition
compared with untreated infected cells). On the contrary, HSV-1 replication was not affected by
DR2B treatment. Next, to demonstrate that the antiviral effect of DR2C was not a consequence of
cytotoxicity, VERO cells were incubated with different concentrations (ranging from 1 to 500 µg/mL)
of DR2C, and cell viability was evaluated by the trypan blue dye exclusion assay. As control, VERO
cells were treated with DMSO. After 24 h of incubation, no significant alteration of cellular morphology
and viability was detected by light microscope observations up to the concentrations of 500 µg/mL.
Cell count of DR2C treated cells was compared to DMSO-treated and untreated cells, and no significant
differences were observed (data not shown). Although the 50% inhibitory concentration (IC50) value
for DR2C was 83.4 µg/mL (Figure 6A), the following experiments were performed using the extract at
500 µg/mL, as the highest antiviral activity was achieved with that dose, which was not cytotoxic.
At first, time-of-addition assays were performed. Vero cells were pre-incubated (PRE) with the
extract for 3 h at 37 ◦C before the viral challenge (i.e., before virus adsorption phase), in order to analyze
its possible interference with some cellular receptors and co-receptors used by HSV-1 to bind the host
cell. Next, DR2C was added to VERO cells during the HSV-1 adsorption phase (ADS) (i.e., during the
very early phase of virus lifecycle). Finally, the extract was administrated to the cellular monolayer
after the viral adsorption phase (POST) for 24 h (i.e., during the early and late phases of the virus
lifecycle). Furthermore, DR2C was also tested as a double dose during, and after, the HSV-1 adsorption
period (ADS+POST). DMSO alone was administered as control. In all the experimental conditions, 24 h
(post infection) p.i., supernatants of infected cells were collected and used to determine viral titer by
standard plaque assay. As shown in Figure 6B, no difference in HSV-1 replication was observed in DR2C
pre-treated cells compared to control (about 106 pfu/mL in both cases). Similarly, DR2C treatment
during viral adsorption did not significantly impair HSV-1 replication (6.5 × 105 pfu/ml vs. 106
pfu/mL). On the contrary, DR2C maintained in cellular culture medium for 24 h after viral adsorption
significantly inhibited viral replication, confirming the trend observed in the previous plaque reduction
assays (3.3 × 103 pfu/mL vs. 106 pfu/mL, i.e., about 2.6-log inhibition). Interestingly, the same
HSV-1 titer reduction was observed in samples treated with a double dose of DR2C, confirming that
the extract was not effective during the virus challenge and showing that the extract affected only
the post adsorption phase of the virus lifecycle, including the synthesis of viral DNA and proteins.
Thus, to check whether DR2C treatment altered viral protein synthesis, we performed a Western blot
by using an antibody directed against the main HSV-1 proteins (ICPs and late). As shown in Figure 6C,
DR2C administration to cells for 24 h after viral adsorption was able to reduce the expression of many
viral proteins, particularly proteins with high and low molecular weight (over 80 kDa and lower
40 kDa, respectively). Furthermore, in the same experimental condition, the viral glycoprotein B (gB,
late protein) expression was also strongly reduced, as confirmed by densitometric analysis (about 60%
reduction compared to DMSO-treated infected cells) (Figure 6C).
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Figure 6. DR2C treatment affects HSV-1 replication. (A) Plaque reduction assay: viral titer of
HSV-1-infected cells treated with increasing concentrations of DR2B and DR2C. Values are expressed
as means ± SD of four experiments, each performed in duplicate. The IC50 of DR2C was calculated by
regression analysis of the dose–response curves. (B) Time-of-addition assay: DR2C was added to Vero
cells before (PRE), during (ADS), or after adsorption for the following 24 h (POST) or as double doses
(ADS+POST). Supernatants were subjected to a standard plaque assay to evaluate viral titer. Data are
expressed as means ± the SD of three independent experiments, each performed in duplicate (* p <
0.05 versus DMSO-treated HSV-1-infected sample). Cell lysates were analyzed by Western blotting (C)
with ti-HSV-1, anti-gB, anti-NOX4, and anti-t bulin antibodies. Densitometric analysis of gB and
NOX4 (lower band) is shown in the graph und r the representative Western blot (* p < 0.05 and ** p <
0.01 vs. DMSO-treated HSV-1-infected cells).
The results obtained in HSV-1-infected cells treated with DR2C are in agreement with previous
studies showing that several stages of HSV-1 replication, favored by oxidative conditions, are affected
by modulation of intracellular redox state [17,79]. To note that although DR2B was able to partially
reduce ROS production induced by tBOOH, it did not restore the GSH levels (see Figure 3B).
Since reducing conditions in i fected host cells are important for the control of viral replication,
the inability of DR2B in restoring the imbalance in the redox state could, in part, explain its inefficacy
against HSV-1 replication. On th contrary, according to the Pearson analysis, the nti-HSV1 activity of
DR2C appears to be significantly correlated with both the radical scavenging and chelating activities
(Table 7), thus suggesting that the samples can counteract the redox imbalance induced by virus in
host cell.
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Table 7. Pearson correlation coefficient among antioxidant activity, cytoprotection against oxidative
stress and antiviral activity for DR2C extract.
Anti-HSV1 Activity vs. Pearson r (CL; R Squared)
DPPH scavenger activity 0.97 * (0.17–0.99; 0.95)
ABTS scavenger activity 0.93 * (0.1–0.99; 0.87)
Hydroxyl radical scavenger activity 0.94 * (0.1–0.99; 0.89)
Fe2+-chelating activity 0.94 * (0.31–0.99; 0.88)
Fe3+-chelating activity 0.97 ** (0.6–0.99; 0.94)
Cytoprotection against tBOOH-induced oxidative stress nsc
* p < 0.05, ** p < 0.01 and *** p < 0.001, statistically significant correlation (two-tailed t-test). CL, confidence limits.
nsc, not significant correlation.
One of the main intracellular sources of ROS is represented by the NADPH (nicotinamide adenine
dinucleotide phosphate) oxidase (NOX) family, constituted by seven enzymes generating superoxide
anion (O2−) or hydrogen peroxide (H2O2), from molecular oxygen [80], that regulate specific cellular
processes. However, they are also activated during acute or chronic viral infections, i.e., influenza
virus and HCV, playing an important role in the regulation of immune response to infections (isoform
NOX2) [81,82] as well as viral replication (isoform NOX4) [75,83–85]. Therefore, we evaluated the effect
of the DR2C on the expression level of NOX4 during HSV-1 infection. To this aim, HSV-1-infected VERO
cells, treated with DR2C at different time of infection, were analyzed by Western blotting to evaluate
NOX-4 expression. As shown in Figure 6C, the anti-NOX4 antibody recognized two NOX4 isoforms,
and the one with a lower molecular weight was completely reduced by DR2C treatment after viral
challenge (POST). It is known that NOX4 is highly expressed in the kidney [86], and that in the human,
there are many NOX4 isoforms produced as splice-variants [87], some of which may have different
functions in ROS-related cell signaling. Unfortunately, scientific literature does not report evidence
about NOX4 isoforms in Cercopithecus aethiops (from which Vero cells are derived); however, we would
mention as evidence that 227 organisms have orthologs with human gene NOX4 (as reported in gene
bank HomoloGene: 41065). Further studies are needed to clarify this aspect.
Among the phytoconstituents of DR2C extracts, as highlighted at phytochemical analysis (Tables 2
and 3), several phenylpropanoids (i.e., chlorogenic acid, caffeic acid, and vanillic acid) and flavonoids
have been reported to possess antiviral properties [88–91]. Along with phenylpropanoids, D3R is one
of the most represented compounds in the DR2C extract, as found by HPTLC densitometric analysis
(Table 2). This compound has been reported to possess several antioxidant properties, and to be able
to protect osteoblastic cells against oxidative damage induced by tert-butyl hydroperoxide [29,69].
Therefore, we tested whether the anti-HSV-1 activity of DR2C was mainly due to this compound.
To this aim, D3R was added to VERO cells at concentration of 5 µg/mL (corresponding to 1% (w/w) of
the first effective DR2C concentration against HSV-1) after HSV-1 adsorption for the following 24 h;
cellular supernatant was collected to perform a standard plaque assay. The treatment with D3R did
not inhibit HSV-1 replication (4 × 105 PFU/mL treated vs. 3.8 × 105 PFU/mL not-treated), suggesting
that DR2C anti-HSV-1 activity depends on the whole phytochemical complex.
Altogether, our results indicate that DR2C is able to significantly impair HSV-1 propagation and
viral protein expression in an in vitro model of VERO cells. To date, the mechanisms underlying the
inhibition are not well defined, however, it is possible to speculate a control by DR2C of NOX4 activity
and redox-regulated pathways during HSV-1 infection.
Importantly, DR2C treatment could also affect viral replication by raising the intracellular
GSH levels in HSV-1-infected VERO cells. In fact, we demonstrated, in the cytoprotective assay
above-described, that DR2C is able to restore the GSH intracellular content in tBOOH-treated
Caco2 cells (Figure 3B). It is known that different acute and chronic viral infections, including that of
Herpes virus, induce a drop of GSH levels in infected cells, which favors viral propagation [17,18].
The administration of GSH or GSH derivative strongly inhibits virus replication by affecting specific
steps of virus lifecycle and restores the GSH content in infected cells. However, further studies are
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in progress in our lab, aimed at clarifying this aspect. The modulation of redox state, through the
re-establishment of reducing conditions in infected cells, may represent a good weapon to contrast
viral infection with the advantage that the virus could have a lower probability to develop resistance.
3. Materials and Methods
3.1. Chemicals
All the chemicals, if not otherwise specified, and the RPMI 1640 medium were obtained from
Sigma-Aldrich Co. (St. Louis, MO, USA). Sodium carbonate, Folin–Ciocalteu’s phenol reagent,
tannic acid, aluminum chloride hexahydrate, and the analytical grade solvents ethyl acetate (AcOEt)
and n-butanol, were purchased from Merck (Darmstadt, Germany). Standard flavonoids and
phenylpropanoids (>95% purity) were obtained from synthesis, and checked by nuclear magnetic
resonance spectroscopy. Delphinidin-3-rutinoside (D3R) and nasunin (NAS) were isolated and
identified from the aubergine berry peel, according to previous methods [28,29].
Fetal bovine serum was obtained from Gibco, while the other reagents for antiviral studies, if not
otherwise specified, were purchased from Invitrogen (Carlsbad, CA, USA).
Anisaldehyde was prepared as a 0.5% (v/v) solution in an ice-cooled mixture of sulfuric acid,
methanol, and acetic acid (1:17:2 v/v/v). Natural product reagent (NPR) was obtained by preparing a
0.5% (w/v) solution of diphenylborinic acid aminoethylester in AcOEt.
3.2. Plant Material and Extract Preparation
Fruits of Solanum melongena L. DR2 homozygous parental line were harvested from open-field
grown plants at the experimental farm in Montanaso Lombardo, at two different fruit ripening
stages, i.e., commercial (B, approximately 38 days after flowering) and physiological ripening (C,
approximately 60 days after flowering). DR2 eggplant is the female parent of the F1 hybrid “Rimina”,
and produces long-shaped dark purple fruit [92]. According to Mennella et al. [33], the fruits at stage
B had reached their final size, and the skin color became less brilliant, with a green ring next to the
skin and a less greenish pulp; the fruits harvested at stage C had an increased firmness, with a peel
color that turned brownish and a spongy and white-yellowish pulp.
The peel from DR2B and DR2C aubergine berries was carefully removed from the pulp, then the
extracts were prepared by maceration in acidified (pH 3) 70% (v/v) EtOH (1:10 drug–solvent ratio or
DSR) and room temperature. The extracts were filtered through no. 1 Whatman paper, and the solvent
was evaporated under vacuum, thus obtaining the dried peel extracts with DER (drug–extract ratio)
values of 1:23 and 1:25 for DR2B and DR2C aubergine berries, respectively.
3.3. Phytochemical Analysis
3.3.1. Determination of Total Polyphenol and Flavonoid Content
The total polyphenol and flavonoid contents were determined according to Di Sotto et al. [62].
The total polyphenol content was calculated as chlorogenic acid equivalents (CAE) per milligram of
sample, while total flavonoids were expressed as quercetin equivalents (QE) per milligram of sample.
3.3.2. High-Performance Thin-Layer Chromatography and Densitometric Analysis
High-performance thin-layer chromatography (HPTLC) and densitometric analysis were carried
out according to Di Sotto et al. [66]. The peel extracts of S. melongena DR2B and DR2C (30 mg/mL
in ethanol) were analyzed in comparison with known polyphenols (e.g., chlorogenic acid at
concentrations of 0.25, 0.5, and 1 mg/mL, while caffeic acid, apigenin, epicatechin, and rutin,
of 1 mg/mL). A HPTLC fingerprint was also determined for anthocyanins, by using NAS
(or delphinidin-3-p-coumaroylrutinoside-5-glucoside), D3R, and delphinidin 3-O-β-D-glucoside
(1 µg/mL) as standard compounds. Polyphenols and anthocyanins were identified by comparison
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with selected standards (Rf values, colors, UV spectra), then a densitometric analysis was performed
by means of a CAMAG DigiStore2 digital system with winCATS software 1.4.3. Repeatability was
determined by running a minimum of three analyses.
3.3.3. HPLC-PDA Analysis
HPLC-PDA phenolic pattern was evaluated by a HPLC Waters liquid chromatography (model
600 solvent pump, 2996 PDA, Waters S.p.A., Milford, MA, USA), according to a previous standardized
method [50]. The peel extracts of S. melongena DR2B and DR2C were weighed (1 mg/mL) and dissolved
in mobile phase, and 20 µL was directly injected into the HPLC-PDA system. For over-range samples,
1:10 dilution factor was applied.
3.4. Cytoprotective Activity against Oxidative Stress
3.4.1. Cell Culture and Treatment
The human colorectal adenocarcinoma (Caco2) cells, obtained from ATCC (American Type Culture
Collection, Manassas, VA, USA), were grown at 37 ◦C in 5% CO2 in Dulbecco’s modified Eagle’s
medium, supplemented with sodium pyruvate (1%), fetal bovine serum (10% v/v), glutamine (2 mM),
streptomycin (100 µg/mL), and penicillin (100 U/mL). Some experiments were also performed under
hypoxia, obtained by culturing cells in a culture medium supplemented with the known chemical
hypoxia inducer cobalt chloride (CoCl2; 100 µM), according to previously published methods [93].
All experiments were performed when cells reached the logarithmic growth phase.
3.4.2. Cytotoxicity and Cytoprotection Assay
The cells were seeded into 96-well microplates (2 × 104 cells/well) and allowed to grow for
24 h; then, progressive dilutions of the DR2B and DR2C extracts in dimethyl sulfoxide (DMSO; 100%
(v/v)) were added to cells (1% (v/v) in the cell medium). The vehicle DMSO was nontoxic at final
concentration of 1% (v/v) in the medium. Cytotoxicity was measured after 24 h incubation with the
samples by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay according to
previous published methods [94]. The assay was carried out three times and, in each experiment, each
concentration was tested almost in six technical triplicates. Cell viability was determined as follows:
[(OD treated cells − OD medium control)/(OD untreated cells − OD medium control)] × 100 (1)
In the cytoprotection assay, after a 24 h pre-treatment with DR2B and DR2C peel extracts,
a low-toxic concentration (about 40% cytotoxicity as found in preliminary experiments) of the
pro-oxidant agent tBOOH (5 µM) was added for 2 h to cells, then, the cell viability was measured as
described above [79].
3.4.3. Determination of Lactate Secretion under Normoxic and Hypoxic Conditions
The levels of lactate, released in the cell medium as a consequence of the glycolytic metabolism,
was measured in both normoxic and hypoxic conditions by the spectrophotometric method described
by Borshchevskaya et al. [95], with some changes. To perform the assay, the cells were subjected to
treatment with DR2B and DR2C extracts (500 µg/mL) for 24 h, both alone and in the presence of
tBOOH (5 µM; 2 h exposure), then, the cell medium was collected for lactate levels determination.
To this end, the cell medium (50 µL) was added with a solution of iron(III) chloride (150 µL; 0.01%
w/v in acetate buffer) and mixed for five minutes, then the absorbance of the formed iron(III) lactate
was measured at 390 nm by a microplate reader (Epoch Microplate Spectrophotometer, BioTeK®
Instruments Inc., Winooski, VT, USA). The lactate levels were normalized to viable cells and expressed
as percentage of the vehicle control.
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3.4.4. Intracellular Levels of Reactive Oxygen Species (ROS) Determination
The ROS levels induced by treatments were measured by the 2,7-dichlorofluorescein diacetate
assay (DCFH-DA), according to Di Giacomo et al. [96] with slight changes. To perform the assay, 5 ×
105 cells were plated into 6-well culture wells. After 24 h incubation, confluent cells (about 60–70%
of confluence) were treated with DR2B and DR2C extracts (500 µg/mL) for 24 h, then a low-toxic
concentration (about 40% cytotoxicity as found in preliminary experiments) of the pro-oxidant agent
tBOOH (5 µM) was added for 2 h to cells. Thereafter, the cells were added with DCFH-DA (10 µM;
6 µL), further incubated for 30 min, then collected and washed twice with HBSS (1×). Fluorescence was
measured at an excitation wavelength of 485 nm and an emission wavelength of 528 nm, using a
BD Accuri™ C6 flow cytometer (BD Biosciences, San Jose, CA, USA). In each experiment, a vehicle
control (corresponding to the basal ROS level) and the pro-oxidant agent t-BOOH were also included;
furthermore, the extracts alone were assayed to evaluate their effect on the basal ROS levels, released
as a consequence of cell metabolism. The mean DCF fluorescence of 1 × 104 cells was measured from
all the treatments. The oxidation index was obtained by the ratio between the DCF fluorescence of the
sample and that of the vehicle control.
3.4.5. Intracellular Levels of Reduced Glutathione (GSH)
Intracellular levels of GSH were determined by the method of Ellman described by Vitalone et al. [97]
with some changes. Briefly, after 24 h treatment, Caco2 cells were suspended in ice-cold hypotonic
lysis buffer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM
phenylmethylsulfonylfluoride, 10 µg/mL aprotinin, and 0.1 mM leupeptin). After 30 min of incubation
at 4 ◦C, lysates were centrifuged at 14,000× g rpm for 30 min, and the supernatants were collected.
Then, equal volumes of supernatants and 5-trichloroacetic acid (10 % w/v) were mixed and centrifuged
at 10,000× g rpm for 5 min. After deproteinization, supernatant (50 µL), PBS (125 µL) and Ellman’s
reagent (25 µL; 30 mM 5,5′-dithiobisnitro benzoic acid in 100 mL of 0.1% sodium citrate) were mixed,
and the absorbance of the yellow product was read at 412 nm by a microplate reader (Epoch Microplate
Spectrophotometer, BioTeK® Instruments Inc., Winooski, VT, USA). The GSH levels were normalized
to viable cells and expressed as percentage.
3.5. Antioxidant Activity Assays
The experiments were performed in 96-multiwell microplates away from direct light, and repeated
at least twice, with three technical replicates. To perform the assays, progressive dilutions of DR2B and
DR2C extracts in 100% (v/v) EtOH were used. In each test, negative or positive controls (Trolox, rutin,
and quercetin) and control wells containing only the tested samples were included. The absorbance
was measured by a microplate reader (Epoch Microplate Spectrophotometer, BioTeK® Instruments Inc.,
Winooski, VT, USA). Some wells containing only the extracts were also included, in order to determine
their possible absorbance.
DPPH, ABTS, and hydroxyl radical scavenging activities were determined according to
Di Sotto et al. [66]. In order to evaluate the ability of the samples to interfere with ROS-generation through
the block of Fenton reaction, the iron chelating and reducing activities were tested [62]. Chelation ability
was evaluated against both ferrous and ferric ions, respectively, while reducing power against ferric ions.
3.6. Antiviral Assay
3.6.1. Cell Culture
African green monkey kidney (Vero) cells, obtained from ATCC (American Type Culture
Collection, Manassas, VA, USA), were grown in RPMI 1640 medium (Sigma Aldrich, St. Louis, MO,
USA) containing 10% heat-inactivated fetal bovine serum (FBS, Gibco), glutamine (0.3 mg/mL),
penicillin (100 units/mL), and streptomycin (100 µg/mL), at 37 ◦C, in an atmosphere of 5% of CO2.
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The effect of the extracts (1–500 µg/mL) on Vero cell viability was tested in vitro by the trypan blue
(0.02% final concentration) exclusion assay.
3.6.2. Virus Production and Infection
For virus production, monolayers of VERO cells in 75 cm2 tissue culture flasks were infected with
HSV-1 (strain F) at a multiplicity of infection (m.o.i.) of 0.01. After 48 h at 37 ◦C, infected cells were
harvested with 3 freeze-and-thaw cycles, cellular debris was removed with low-speed centrifugation,
and the virus titer was measured by a standard plaque assay, as described above. The titer of the
virus preparation was 109 plaque forming units (PFU)/mL. The virus was stored at −80 ◦C until use.
For in vitro HSV-1 infection, confluent monolayers of Vero cells in 24-well plates were incubated with
HSV-1 at a m.o.i. of 1 for 1 h at 37 ◦C, to allow virus adsorption to the host cells (adsorption phase).
Then, the medium was replaced with fresh medium supplemented with 2% FBS, and the plates were
maintained for 24 h at 37 ◦C in an atmosphere of 5% CO2 (post-infection phase).
3.6.3. Determination of Viral Yields
The antiviral activity of DR2B and DR2C extracts was evaluated by plaque reduction and standard
plaque assays as previously described in Marcocci et al. [12]. Briefly, to perform a plaque reduction
assay, Vero cells grown in 24-well plates were infected with HSV-1 at 1 m.o.i. and, after 1 h at 37 ◦C
(viral adsorption period), were washed with PBS and the medium replaced with RPMI containing
1% carboxymethylcellulose (CMC), 2% FBS, and different concentrations of DR2B and DR2C extracts
(1–500 µg/mL) or DMSO as control. After 36/48 h at 37 ◦C plaque formation was scored, and the viral
titer calculated as PFU/mL. To perform a standard plaque assay, confluent monolayer Vero cells were
infected with different dilutions of supernatant of infected cells, and after 1 h at 37 ◦C (viral adsorption
phase), the medium was replaced with RPMI containing 2% CMC and 2% FBS. After 48 h at 37 ◦C,
monolayers were fixed with cold methanol for 20 min at −20 ◦C, and then stained with a 0.5% crystal
violet solution. The plaques were counted, and the viral titer calculated as PFU/mL.
3.6.4. Time-of-Addition Assay
DR2C extract was added at the final concentration of 500 µg/mL at different times of
HSV-1 infection: (i) cells were pre-incubated for 3 h (pre-viral adsorption phase) with DR2C; (ii) DR2C
was added only during or after viral adsorption phase; (iii) the extract was added during and
post-adsorption phase. After 24 h of infection, the supernatants were collected and used to determine
HSV-1 titer with standard plaques assay, as described before.
3.6.5. Western Blot Analysis
Vero cells were washed with PBS, resuspended in cold lysis buffer (10 mM Tris-HCl, 150 mM NaCl,
1 mM phenylmethylsulfonyl fluoride, phosphatase inhibitor mixture (Sigma, St. Louis, MO, USA),
and 1% Triton X-100, pH 7.4), and incubated for 30 min on ice. After centrifugation (10,000× g for 30 min
at 4 ◦C) the supernatants were collected and assayed to determine their protein concentration (Bradford
method, Bio-Rad, Hercules, CA, USA). Equivalent amounts of proteins were separated with SDS-PAGE,
and blotted onto nitrocellulose membranes for Western blot analysis. The membranes were blocked
with 10% nonfat dry milk in TBS, 1% Tween-20 for 1 h at room temperature, and incubated with primary
antibodies: goat polyclonal anti-HSV (AbD Serotec, Oxford, UK), mouse monoclonal anti-glycoprotein
B (Santacruz Biotechnology, Dallas, TX, USA), rabbit polyclonal anti-NOX4 (Santacruz Biotechnology,
Dallas, TX, USA), or mouse monoclonal anti-tubulin (Sigma Aldrich, St. Louis, MO, USA) at a final
concentration of 1 µg/mL. Secondary antibodies were horseradish peroxidase-conjugated (Jackson
ImmunoResearch, West Grove, PA, USA). Blots were developed with the Pierce ECL Plus Western
Blotting Substrate (Thermo Scientific, Waltham, MA, USA) and subjected to densitometric scanning.
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3.7. Statistical Analysis
All values are expressed as mean ± SE or mean ± SD, as indicated. Statistical analysis
was performed by GraphPad Prism™ software (GraphPad Software, Inc., San Diego, CA, USA).
The one-way analysis of variance (one-way ANOVA), followed by Dunnett’s multiple comparison
post-test, was used to analyze the difference between treatments. Moreover, unpaired data were
analyzed with Student’s t-test. The concentration–response curves were constructed using the “Hill
equation”: E = Emax/[1 + (10LogEC50/A)HillSlope], where E is the effect at a given concentration of
agonist, Emax is the maximum activity, IC50 is the concentration that produces a 50% of the inhibitory
response, A is the agonist concentration in molar, and HillSlope is the slope of the agonist curve.
P values of less than 0.05 (p < 0.05) were considered statistically significant. The concentration of
the extracts required to reduce virus yield by 50% (IC50) was calculated by regression analysis of the
dose–response curves.
4. Conclusions
Eggplants are known around the world as a vegetable crop of nutritional interest, due to their
content of high amounts of vitamins, phenolics, and anthocyanins. However, they have been used
in traditional medicine as a remedy for several ailments, including skin diseases and infections.
Particularly, slices of eggplant stalks and berry peel were applied on the skin to treat frostbites, burns,
and skin warts (known to be induced by human papillomavirus), although the scientific basis is
lacking. Here, we described the antioxidative cytoprotective properties and the anti-herpetic activity
of an ethanolic DR2C extract, obtained from the berry peel of a DR2 eggplant, which has been selected
to contain high levels of delphinidin-3-rutinoside (D3R). Physiological ripeness has been highlighted
to be the only suitable stage at which the antiviral activity was exerted. A lack of antiviral activity of
D3R under our experimental conditions suggests that other phytoconstituents can be responsible for
the anti-HSV-1 activity of DR2C. Among them, literature data support the possible role of chlorogenic
acid, although no effects were found for the DR2B extract, whose chlorogenic acid amount was higher
than that of DR2C. Therefore, the contribution of other phenolics or phytochemical groups, such as
glycoalkaloids, is expected. However, taking into account the possible synergistic and/or antagonistic
interactions that can occur under a phytocomplex, the true pharmacodynamic and/or pharmacokinetic
contribution of DR2C phytoconstituents remains to be clarified.
To date, our study is the first demonstration of the in vitro anti-HSV-1 activity of eggplant
peel, due to multitargeted mechanisms, including the restoration of intracellular redox state that
HSV-1 modulates to promote its replication in the host cells. Further studies are needed to deeply
characterize the possible application of DR2C extract as an anti-HSV-1 remedy.
Altogether, these results provide preliminary scientific evidence on the traditional use of eggplant,
and highlight a possible new interest for aubergine berry peel, which often represents a waste product,
as a nutraceutical and pharmaceutical source for further development of anti-herpetic remedies.
Supplementary Materials: The following are available online, Figure S1: High-performance thin-layer
chromatography (HPTLC) of the polyphenolic compounds of DR2B and DR2C extracts, Figure S2: HPTLC
(300 nm) chromatograms and densitometric analysis (peak list, Rf values and abundance of revealed compounds)
of DR2B and DR2C extracts, Figure S3: HPLC-PDA (278 nm) chromatograms of DR2B and DR2C extracts,
Figure S4: Effect of DR2B and DR2C extracts the viability and lactate secretion of Caco2 cells under normoxia and
cobalt chloride (CoCl2)-induced hypoxia.
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